Wayne Grover Brisbane

Title(s)Assistant Professor-in-Residence, Urology
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes. BJUI Compass. 2025 Jan; 6(1):e456. Brisbane WG, Priester AM, Nguyen AV, Topoozian M, Mota S, Delfin MK, Gonzalez S, Grunden KP, Richardson S, Natarajan S, Marks LS. PMID: 39877558; PMCID: PMC11771490.
      View in: PubMed   Mentions:
    2. Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm. BJUI Compass. 2024 Oct; 5(10):986-997. Priester A, Mota SM, Grunden KP, Shubert J, Richardson S, Sisk A, Felker ER, Sayre J, Marks LS, Natarajan S, Brisbane WG. PMID: 39416757; PMCID: PMC11479810.
      View in: PubMed   Mentions: 1  
    3. Evaluation of prostate cancer detection using micro-ultrasound versus MRI through co-registration to whole-mount pathology. Sci Rep. 2024 08 14; 14(1):18910. Pensa J, Brisbane W, Kinnaird A, Kuppermann D, Hughes G, Ushko D, Priester A, Gonzalez S, Reiter R, Chin A, Sisk A, Felker E, Marks L, Geoghegan R. PMID: 39143293; PMCID: PMC11324719.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Inter-reader Agreement for Prostate Cancer Detection Using Micro-ultrasound: A Multi-institutional Study. Eur Urol Open Sci. 2024 Aug; 66:93-100. Zhou SR, Choi MH, Vesal S, Kinnaird A, Brisbane WG, Lughezzani G, Maffei D, Fasulo V, Albers P, Zhang L, Kornberg Z, Fan RE, Shao W, Rusu M, Sonn GA. PMID: 39076245; PMCID: PMC11284543.
      View in: PubMed   Mentions:
    5. Creation and validation of a novel low-cost dry lab for early resident training and assessment of robotic prostatectomy technical proficiency. Curr Urol. 2024 Jun; 18(2):133-138. Kunitsky K, Venkataramana A, Fero KE, Ballon J, Komberg J, Reiter R, Brisbane W. PMID: 39176295; PMCID: PMC11337995.
      View in: PubMed   Mentions:
    6. Artificial Intelligence Improves the Ability of Physicians to Identify Prostate Cancer Extent. J Urol. 2024 Jul; 212(1):52-62. Mota SM, Priester A, Shubert J, Bong J, Sayre J, Berry-Pusey B, Brisbane WG, Natarajan S. PMID: 38860576; PMCID: PMC11178250.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial. Cancers (Basel). 2024 Jun 08; 16(12). George AK, Miocinovic R, Patel AR, Lomas DJ, Correa AF, Chen DYT, Rastinehad AR, Schwartz MJ, Uchio EM, Sidana A, Helfand BT, Gahan JC, Yu A, Vourganti S, Barqawi AB, Brisbane WG, Wysock JS, Polascik TJ, McClure TD, Coleman JA. PMID: 38927884; PMCID: PMC11201469.
      View in: PubMed   Mentions:
    8. Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancer. World J Urol. 2024 Mar 16; 42(1):165. Nikitas J, Kishan A, Chang A, Duriseti S, Nichols NG, Reiter R, Rettig M, Brisbane W, Steinberg ML, Valle L. PMID: 38492111.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. MicroSegNet: A deep learning approach for prostate segmentation on micro-ultrasound images. Comput Med Imaging Graph. 2024 03; 112:102326. Jiang H, Imran M, Muralidharan P, Patel A, Pensa J, Liang M, Benidir T, Grajo JR, Joseph JP, Terry R, DiBianco JM, Su LM, Zhou Y, Brisbane WG, Shao W. PMID: 38211358.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Point of View: Innovation and Progress for Screening and Management of Localized Prostate Cancer: What an Exciting Time. J Urol. 2024 Feb; 211(2):317-319. Tosoian JJ, Yu A, Brisbane WG. PMID: 38010955.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    11. Assessing cancer risk in the anterior part of the prostate using micro-ultrasound: validation of a novel distinct protocol. World J Urol. 2023 Nov; 41(11):3325-3331. Schaer S, Rakauskas A, Dagher J, La Rosa S, Pensa J, Brisbane W, Marks L, Kinnaird A, Abouassaly R, Klein E, Thomas L, Meuwly JY, Parker P, Roth B, Valerio M. PMID: 37712968; PMCID: PMC10632243.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Hyaluronan Metabolism in Urologic Cancers. Adv Biol (Weinh). 2023 12; 7(12):e2300168. Donelan W, Brisbane W, O'Malley P, Crispen P, Kusmartsev S. PMID: 37615259.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    13. The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement. Prostate Cancer Prostatic Dis. 2024 Dec; 27(4):579-581. Javier-DesLoges J, Dall'Era MA, Brisbane W, Chamie K, Washington SL, Chandrasekar T, Marks LS, Nguyen H, Daneshvar M, Gin G, Kane CJ, Bagrodia A, Cooperberg MR. PMID: 37553435.
      View in: PubMed   Mentions: 2     Fields:    
    14. Development and Validation of a Mixed-Reality Simulator for Reducing Biopsy Core Deviation During Simulated Freehand Systematic Prostate Biopsy. Simul Healthc. 2024 Apr 01; 19(2):105-112. Lampotang S, Lizdas DE, Johnson WT, Mei V, Wakim J, Lou X, DeStephens A, Acar Y, Moy L, Ahmad A, Brisbane W, Stringer T. PMID: 36976805.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes. Cancer Med. 2023 04; 12(8):9351-9362. Aker MN, Brisbane WG, Kwan L, Gonzalez S, Priester AM, Kinnaird A, Delfin MK, Felker E, Sisk AE, Kuppermann D, Marks LS. PMID: 36775929; PMCID: PMC10166973.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    16. Utility of Magnetic Resonance Imaging for Localizing Prostate Cancer Near the Urethra in Men Who Are Candidates for Focal Gland Ablation. J Urol. 2023 05; 209(5):911-917. Patel N, Hughes A, Zhang JH, Brisbane W, Rastegarpour A, Afsahir S, Kwan L, Nguyen AV, Sisk A, Raman S, Reiter R. PMID: 36753630.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Micro-Ultrasound Guided Transperineal Prostate Biopsy: A Clinic-Based Procedure. J Vis Exp. 2023 02 03; (192). Ashouri R, Nguyen B, Archer J, Crispen P, O'Malley P, Su LM, Grajo J, Falzarano SM, Acar Y, Lizdas D, Lampotang S, Brisbane W. PMID: 36805636.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. Cancers (Basel). 2022 Dec 28; 15(1). Miyagi H, Kwenda E, Ramnaraign BH, Chatzkel JA, Brisbane WG, O'Malley P, Crispen PL. PMID: 36612164; PMCID: PMC9817944.
      View in: PubMed   Mentions: 3  
    19. Partial Gland Ablation of Prostate Cancer: Effects of Repeat Treatment. Urology. 2022 12; 170:161-167. Nassiri N, Richardson S, Kuppermann D, Brisbane WG, Gonzalez S, Kwan L, Felker E, Wallner C, Marks LS. PMID: 35907484.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. A prostate cancer risk calculator: Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men. Can Urol Assoc J. 2022 Mar; 16(3):E161-E166. Kinnaird A, Brisbane W, Kwan L, Priester A, Chuang R, Barsa DE, Delfin M, Sisk A, Margolis D, Felker E, Hu J, Marks LS. PMID: 34672937; PMCID: PMC8923894.
      View in: PubMed   Mentions: 6  
    21. Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling. Eur Urol. 2022 09; 82(3):303-310. Brisbane WG, Priester AM, Ballon J, Kwan L, Delfin MK, Felker ER, Sisk AE, Hu JC, Marks LS. PMID: 35115177.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimals
    22. The utility of prostate MRI within active surveillance: description of the evidence. World J Urol. 2022 Jan; 40(1):71-77. Dominique G, Brisbane WG, Reiter RE. PMID: 34860274; PMCID: PMC8813688.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer. J Urol. 2022 04; 207(4):823-831. Kinnaird A, Yerram NK, O'Connor L, Brisbane W, Sharma V, Chuang R, Jayadevan R, Ahdoot M, Daneshvar M, Priester A, Delfin M, Tran E, Barsa DE, Sisk A, Reiter RE, Felker E, Raman S, Kwan L, Choyke PL, Merino MJ, Wood BJ, Turkbey B, Pinto PA, Marks LS. PMID: 34854746; PMCID: PMC10506469.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. A System for Co-Registration of High-Resolution Ultrasound, Magnetic Resonance Imaging, and Whole-Mount Pathology for Prostate Cancer. Annu Int Conf IEEE Eng Med Biol Soc. 2021 11; 2021:3890-3893. Pensa J, Brisbane W, Priester A, Sisk A, Marks L, Geoghegan R. PMID: 34892082.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Editorial Comment. J Urol. 2022 01; 207(1):105. Marks LS, Brisbane WG. PMID: 34633211.
      View in: PubMed   Mentions:    Fields:    
    26. Editorial Comment. J Urol. 2022 01; 207(1):117. Marks LS, Brisbane WG, Priester AM. PMID: 34601895.
      View in: PubMed   Mentions:    Fields:    
    27. Textured-Based Deep Learning in Prostate Cancer Classification with 3T Multiparametric MRI: Comparison with PI-RADS-Based Classification. Diagnostics (Basel). 2021 Sep 28; 11(10). Liu Y, Zheng H, Liang Z, Miao Q, Brisbane WG, Marks LS, Raman SS, Reiter RE, Yang G, Sung K. PMID: 34679484; PMCID: PMC8535024.
      View in: PubMed   Mentions: 12  
    28. Focal Laser Ablation of Prostate Cancer: An Office Procedure. J Vis Exp. 2021 03 30; (169). Brisbane WG, Natarajan S, Priester A, Felker ER, Kinnaird A, Marks LS. PMID: 33871450.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Relationship Between Mobile Digital Sensor Monitoring and Perioperative Outcomes: Systematic Review. JMIR Perioper Med. 2021 Feb 25; 4(1):e21571. Memon A, Lec P, Lenis A, Sharma V, Wood E, Schade G, Brisbane W. PMID: 33629966; PMCID: PMC7952235.
      View in: PubMed   Mentions: 1  
    30. The role of neoadjuvant chemotherapy, lymph node dissection, and treatment delay in patients with muscle-invasive bladder cancer undergoing partial cystectomy. Urol Oncol. 2021 08; 39(8):496.e17-496.e24. Lenis AT, Fero KE, Ojeaburu L, Lec PM, Golla V, Brisbane W, Leapman MS, Chamie K. PMID: 33640225.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. Editorial Comment. J Urol. 2021 03; 205(3):798. Marks LS, Brisbane WG. PMID: 33393830.
      View in: PubMed   Mentions:    Fields:    
    32. The Role of Opioids and Their Receptors in Urological Malignancy: A Review. J Urol. 2020 Dec; 204(6):1150-1159. Lec PM, Lenis AT, Golla V, Brisbane W, Shuch B, Garraway IP, Reiter RE, Chamie K. PMID: 32516030.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival. Urol Oncol. 2020 10; 38(10):796.e7-796.e14. Lenis AT, Lec PM, Michel J, Brisbane W, Golla V, Sharma V, Gollapudi K, Blumberg J, Chamie K. PMID: 32446641.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study. Urol Oncol. 2020 11; 38(11):854.e1-854.e9. Lec PM, Lenis AT, Brisbane W, Sharma V, Golla V, Gollapudi K, Blumberg J, Drakaki A, Bergman J, Chamie K. PMID: 32430252.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Sodium Fluorescein for Identification of Intraoperative Urine Leaks During Partial Nephrectomy. Urology. 2020 08; 142:249. Kunitsky K, Lec PM, Brisbane W, Lenis AT, Chamie K. PMID: 32387291.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Comparison of clinician and patient users of a mobile phone application to assess penile curvature in Peyronie's disease. Int J Impot Res. 2020 Jul; 32(4):401-408. Brisbane WG, Rogers MJ, Hsi RS, Rajanahally S, Schade GR, Trew L, Ostrowski KA, Wessells H, Walsh TJ. PMID: 31068689.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. AUTHOR REPLY. Urology. 2019 03; 125:153. Brisbane WG, Schade GR. PMID: 30798965.
      View in: PubMed   Mentions:    Fields:    
    38. The relationship between cannabis and male infertility, sexual health, and neoplasm: a systematic review. Andrology. 2019 03; 7(2):139-147. Rajanahally S, Raheem O, Rogers M, Brisbane W, Ostrowski K, Lendvay T, Walsh T. PMID: 30767424.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    39. WITHDRAWN: Moving Patient Reported Outcomes Toward Disease-specific Knowledge. Urology. 2018 Dec 18. Brisbane WG, Schade GR. PMID: 30571985.
      View in: PubMed   Mentions:    Fields:    
    40. Nonmuscle Invasive Bladder Cancer Influences Physical Health Related Quality of Life and Urinary Incontinence. Urology. 2019 03; 125:146-153. Brisbane WG, Holt SK, Winters BR, Gore JL, Walsh TJ, Wright JL, Schade GR. PMID: 30552938.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. Anaphylactoid Reactions After Instillation of Contrast Material Into the Urinary Tract: A Survey of Contemporary Practice Patterns and Review of the Literature. Urology. 2018 Dec; 122:58-63. Dai JC, Brisbane WG, Chang HC, Hsi RS, Harper JD. PMID: 30195013.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016 11; 13(11):654-662. Brisbane W, Bailey MR, Sorensen MD. PMID: 27578040; PMCID: PMC5443345.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    43. Comparing radiation exposure between ablative therapies for small renal masses. J Endourol. 2013 Dec; 27(12):1435-9. Arnold DC, Schroeder G, Smith JC, Wahjudi IN, Heldt JP, Richards GD, Agarwal G, Brisbane WG, Farley DV, Baldwin DD. PMID: 24127631.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Reply by the authors. Urology. 2013 Feb; 81(2):470-1. Brisbane W, Olgin G, Baldwin DD. PMID: 23374836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Radiation exposure during continuous and pulsed fluoroscopy. J Endourol. 2013 Mar; 27(3):384-8. Smith DL, Heldt JP, Richards GD, Agarwal G, Brisbane WG, Chen CJ, Chamberlin JD, Baldwin DD. PMID: 22966826.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    46. Fluoro-less ureteral stent placement following uncomplicated ureteroscopic stone removal: a feasibility study. Urology. 2012 Oct; 80(4):766-70. Brisbane W, Smith D, Schlaifer A, Anderson K, Baldwin DD. PMID: 22950998.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    Wayne's Networks
    Concepts (130)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (35)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-12-gbedcc43d on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California